The Philippine Food and Drug Administration (FDA) on Tuesday said it has issued a summons with a cease and desist order against pharmaceutical giant Sanofi Pasteur Inc. for airing television and radio advertisements of its dengue vaccine, Dengvaxia.
The FDA said the airing of the advertisement violates Administrative Order No. 65 s. 1989, prohibiting advertisement in any form of prescription or ethical drugs.
In a statement, the FDA's Center for Drug Regulation and Research (CDRR) said it has monitored the airing of the advertising materials on the dengue vaccination.
It has also reported the unauthorized promotion of the dengue vaccine in the malls.
In the summons issued by the FDA last Dec. 13, Sanofi was directed to cease and desist from disseminating advertisements for Dengvaxia in any form of mass or social media.
Sanofi was also directed to stop activities promoting and marketing the vaccine. However, as of last Dec. 15, the company has failed to comply with the FDA's directive to take down the advertisements.
"Since Sanofi has not complied, we have issued a summons directing them to cease and desist from airing the advertisements and show cause why they should not be penalized for violating the law," FDA director general Nela Charade Puno said.
Puno added that to ensure immediate compliance, "the FDA already sent letters to TV and radio stations directing them not to air the said unauthorized ads".
She also said the FDA will monitor the compliance of Sanofi and the stations.
"We are looking forward to their cooperation in our mandate to ensure that the public is provided only with the correct information on the food, drugs, cosmetics, and health devices they use," Puno pointed out.
Source: Philippines News Agency